论文部分内容阅读
目的:观察肠复方配合化疗治疗大肠癌的临床疗效。方法:将60例晚期大肠癌患者随机分为肠复方加化疗组和单 纯化疗组,并对其两组治疗前后肿瘤病灶、临床证侯、生存质量、癌胚抗原、自然杀伤细胞活性等指标进行临床疗效分析和组 间比较。结果:肠复方配合化疗治疗结肠癌的疗效明显优于单纯化疗组,并能有效的缓解临床证侯,提高患者生活质量,促进 癌胚抗原转阴和增强机体抗肿瘤免疫。结论:肠复方合并化疗治疗大肠癌确有明显疗效。
Objective: To observe the clinical curative effect of intestine combined with chemotherapy in treating colorectal cancer. Methods: Sixty patients with advanced colorectal cancer were randomly divided into two groups: intestine plus chemotherapy group and chemotherapy alone group, and their tumor lesions, clinical symptoms, quality of life, carcinoembryonic antigen and natural killer cell activity were measured before and after treatment Clinical efficacy analysis and comparison between groups. Results: Intestinal compound chemotherapy combined with chemotherapy for colon cancer was significantly better than the chemotherapy alone group, and can effectively alleviate the clinical syndrome, improve patient quality of life, promote carcinoembryonic antigen negative and enhance the body anti-tumor immunity. Conclusion: Integrative compound chemotherapy in the treatment of colorectal cancer does have a significant effect.